Notify me when Avenue Venture Opportunities Fund, L.P. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| XAIR | BEYOND AIR, INC. | Common Stock, par value $0.0001 per share | 8.9% | $1,695,303 | 8,072,872 | Avenue Capital Management II, L.P. | 31 Dec 2024 | ||
| CTSO | Cytosorbents Corp | Common Stock, par value $0.001 per share | 5.7% | $4,356,117 | 3,755,273 | Avenue Capital Management II, L.P. | 26 Jun 2024 | ||
| HYPD | HYPERION DEFI, INC. | COMMON STOCK, par value $0.0001 per share | 4.2% | $1,592,022 | -$756,927 | 240,124 | -32% | Avenue Capital Management II, L.P. | 17 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|